Altana To Sue Generics Maker Over Protonix ANDA

Law360, New York (April 5, 2004, 12:00 AM EDT) -- German drug maker Altana said it will take legal steps against a patent challenge for its ulcer drug pantoprazole from a generic competitor in the U.S., the company said in a statement on Monday.

An unnamed drugmaker is challenging Altana's patents on Protonix with the U.S. Food and Drug Administration, Altana said.

"Altana will, together with its American partner Wyeth, take all necessary legal steps against any imitator," Altana Chief Executive Hans-Joachim Lohrisch said in a statement.

Marketed with Wyeth in the U.S. as Protonix, the...
To view the full article, register now.

UK Financial Services

UK Financial Services

Read Our Latest UK Financial Services Coverage

Financial Services Law360 UK provides breaking news and analysis on the financial sector. Coverage includes UK and European Union policy, enforcement, and litigation involving banks, asset management firms, and other financial services organizations.